Molecular residual disease analysis of adjuvant osimertinib in resected EGFR-mutated stage IB-IIIA non-small-cell lung cancer
EGFR突变型IB-IIIA期非小细胞肺癌切除术后辅助奥希替尼治疗的分子残留病灶分析
期刊:Nature Medicine
影响因子:50
doi:10.1038/s41591-025-03577-y
Herbst, Roy S; John, Thomas; Grohé, Christian; Goldman, Jonathan W; Kato, Terufumi; Laktionov, Konstantin; Bonanno, Laura; Tiseo, Marcello; Majem, Margarita; Dómine, Manuel; Ahn, Myung-Ju; Kowalski, Dariusz M; Pérol, Maurice; Sriuranpong, Virote; Özgüroğlu, Mustafa; Bhetariya, Preetida; Markovets, Aleksandra; Rukazenkov, Yuri; Muldoon, Caitlin; Robichaux, Jacqulyne; Hartmaier, Ryan; Tsuboi, Masahiro; Wu, Yi-Long